Abstract
Systemic and hepatic hemodynamics wereprospectively studied in 11 patients with Manson'sschistosomiasis and portal hypertension, as well asalterations resulting from the use of propranolol. Itwas decided that patients whose portal pressure was reducedby 30% with the use of the drug would not undergosurgery and that treatment would consist of the chronicuse of propranolol, associated with sclerosis of esophageal varices. This objective was not metby any of the patients whose portal pressure wasmeasured and the study was interrupted. Results showthat patients with Manson's schistosomiasis and portal hypertension have hyperdynamic circulation,mild pulmonary hypertension, greatly increased splenicblood flow, and preservation of total hepatic bloodflow. Administration of propranolol correctshyperdynamic circulation, aggravates pulmonary hypertension,does not alter portal pressure and reduces the sectorialportal blood flows, especially of the azygos vein, withmaintenance of total hepatic blood flow. These data favor the hypothesis of portaloverflow in the physiopathology of portal hypertensionof schistosomiasis.
Similar content being viewed by others
REFERENCES
Alves CAP, Alves AR, Abreu WN, Andrade ZA: Hepatic artery hypertrophy and sinusoidal hypertension in advanced schistosomiasis. Gastroenterology 72:126–128, 1977
Ramos OL, Saad F, Leser WP: Portal hemodynamics and liver cell function in hepatic schistosomiasis. Gastroenterology 47:241–247, 1964
Strauss E, Silva LC, Raia S: Fluxo sangümeo hepático. Arq Gastroenterol 13:41–50, 1976
Raia S, Mies S, Alfieri Jr. F: Portal hypertension in mansonic schistosomiasis. World J Surg 5:176–187, 1991
Andrade ZA, Cheever AW: Alterations of the intrahepatic vasculature in hepatosplenic schistosomiasis mansoni. Am J trop Med Hyg 20:425–432, 1971
Morgan JS, Groszmann RJ, Rojkind M, Enriquez R: Hemodynamic mechanisms of emerging portal hypertension caused by schistosomiasis in the hamster. Hepatology 11:98–104, 1990
Coutinho A: Altera{ie759-1}s hemodinâmicas na esquistossomose mansônica hepato-esplenica. J Bras Med 8:299–309, 1964
Andrade ZA, Andrade SG: Patologia da esquistossomose hepatesplènica. In Aspectos peculiares da infec{ie759-2} por Schistosoma mansoni. ES Azevedo, G Rebouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didático da UFBA, 1984, pp 103–131
Lopes de Faria J: Pulmonary arteriovenous fistulas and arterial distribution of eggs of Schistosoma mansoni. Am J trop Med Hyg 5:860–862, 1956
Lebrec D, Nouel O, Corbic M, Benhamou JP: Propranolol. A medical treatment for portal hypertension? Lancet 2:180–182, 1980
Lebrec D: β-Blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding. Hepatogastroenterology 37:556–560, 1990
Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Bermann MM, Patrick MJC, Morse SS, Alberts JL: Shortterm effects of propranolol on portal venous pressure. Hepatology 6:101–106, 1986
Rector WG Jr: Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal veins pressure. Arch Intern Med 145:648–650, 1985
Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, Audano M: Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 7:648–653, 1987
Bosch J, Garcia-Pagán JC, Feu F, Luca A, Fernandez M, Pizcueta P, Rodes J: New approaches in the pharmacological treatment of portal hypertension. J Hepatol 17:841–845, 1993
Pagliaro L, D'Amico G, Tine F, Pasta L: Prevention of upper gastrointestinal bleeding from portal hypertension in cirrhosis: rationale for medical treatment. Dig Dis 10:56–64, 1992
Acharya SK, Dasarathy S, Saksema S, Pande JH: A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol 19:291–300, 1993
Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S: Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol 19:301–311, 1993
Mies S, Pereira MB, Orlando CD, Sette M, Raia S: Propranolol na preven{ie759-3} da recidiva de hemorragia digestiva em pacientes com esquistossomose hepatesplènica. Rev Assoc Med Bras 34:24–28, 1988
Coelho JL: Propranolol em portadores de hipertensão portal esquistossomótica (estudos hemodinâmicos). Thesis. Faculdade de Medicina, Universidade de São Paulo, São Paulo, 1987
Rao PS, Quesada LC, Mueller HS: A simple micromethod for simultaneous determination of plasma propranolol and 4-hydroxypropranolol. Clin Chim Acta 88:355–361, 1978
Baselt RC (ed): Propranolol. In Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology. Davis, Biomedical, 1980, pp 248–252
Lunderquist A, Vang J: Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 291:646–649, 1974
Bosch J, Feu F, Garcia-Pagan JC: Measurement of azygos blood flow. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Spring-Verlag, 1991, pp 139–150
Bosch J, Groszmann RJ: Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 4:424–429, 1984
Villeneuve JP, Huot R, Marleau D, Huet PM: The estimation of hepatic blood flow with indocyanine green: Comparison between the continuous infusion and single injection methods. Am J Gastroenterol 77:233–237, 1982
Barash PG, Kopriva CJ: Cardiac pump function and how to monitor it. In Manual of Cardiac Anesthesia. SJ Thomas (ed). New York, Churchill Livingstone, 1984, pp 1–34
Shoemaker WC: Monitoring of the critically ill patient. In Textbook of Critical Care. WC Shoemaker, WL Thompson, PR Holbrook (eds). Philadelphia, Saunders, 1984, pp 105–121
Ohnishi K, Chin N, Tanaka H, Iida S, Sato S, Terabayashi H, Nomura F: Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension. Am J Gastroenterol 84:409–412, 1989
Lautt WW, Greenway CV: Conceptual review of the hepatic vascular bed. Hepatology 7:952–963, 1987
Coutinho A: Hemodynamic studies of portal hypertension in schistosomiasis. Am J Med 44:547–556, 1968
Carneiro JLA: A circula{ie760-1} colateral gastresofágica após desconexão ázigo-portal. Portografia trans-hepática na esquistossomose mansônica. Thesis. Centro Biomédico Universidade Federal do Espírito Santo, Vitória, 1979
Shand DG: Individualization of propranolol therapy. Med Clin North Am 58:1063–1069, 1974
Lindenfeld J, Crawford MH, O'Rourke RA, Levine SP, Montiel MM, Hosrwitz LD: Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 62:704–711, 1980
Biber B, Holm C, Winsö O, Gustavsson B: Portal blood flow in man during surgery, measured by a modification of the continuous thermodilution method. Scand J Gastroenterol 18:233–239, 1983
Fomon JJ, Warren WD: Hemodynamic studies in portal hypertension. Annu Rev 20:277–290, 1969
Bosch J, Ginés P, Arroyo V, Navasa M, Rodes J: Hepatic and systemic hemodynamics and the neurohumoral systems in cirrhosis. In The Kidney in Liver Disease, 3rd ed. M Epstein (ed). Baltimore, Williams & Wilkins, 1988, pp 286–305
Lebrec D: Hepatic vein catheterization. In Portal Hypertension. Clinical and Phisiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Springer-Verlag, 1991, pp 117–125
Lautt WW, Greenway CV: Hepatic circulation in homeostasis. In The Kidney in Liver Disease, 3rd ed. M Epstein (ed). Baltimore, Williams & Wilkins, 1988, pp 244–261
Jenkins WJ, Billing B: Physiology of the liver. In Bockus Gastroenterology, Vol 5, 4th ed. JE Berk (ed). Philadelphia, Saunders, 1985, pp 2666–2696
Meyers WC: Anatomy and physiology. In Textbook of Surgery. The Biological Basis of Modern Surgical Practice, 13th ed. DC Sabiston Jr (ed). Philadelphia, Saunders, 1986, pp 1053–1068
Henderson JM, Warren WD: Surgical complications of cirrhosis and portal hypertension. In Textbook of Surgery. The Biological Basis of Modern Surgical Practice, 13th ed. DC Sabiston Jr (ed). Philadelphia, Saunders, 1986, pp 1095–1116
Mahl TC, Groszmann RJ: The pathophysiology of portal hypertension. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Springer-Verlag, 1991, pp 27–33
Bradley SE, Ingelfinger FJ, Bradley GP, Curry JJ: The estimation of hepatic blood flow in man. J Clin Invest 24:890–897, 1945
Leevy CM, Mendenhall CL, Lesko W, Howard MM: Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169–1180, 1962
Rowell LB, Blackmon JR, Bruce RA: Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43:1677–1690, 1964
Frishman WH: Pharmacodynamic and pharmacokinetic properties. In Clinical Pharmacology of the Beta-Adrenoceptor Blocking Drugs. WH Frishamn (ed). New York, Appleton, 1980, pp 1–14
MacMathuna P, Viavianos P, Wendon J, Gove CD, Westaby D, Williams R: Metabolic effects of β-receptor blockade in advanced alcoholic cirrhosis. J Hepatol 17:74–80, 1993
Bendtsen F, Christense NJ, Sörensen TIA, Henriksen JH: Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis. Hepatology 14:237–243, 1991
Braillon A, Calès P, Valla D, Gaudy D, Geoffroy P, Lebrec D: Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 27:1204–1209, 1986
Schrier RW, Caramelo C: Hemodynamics and hormonal alterations in hepatic cirrhosis. In The Kidney in Liver Disease. M Epstein (ed). Baltimore, Williams & Wilkins, 1988, pp 265–285
Bonizon A, Blendis LM: The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 20:1343–1350, 1994
Shelmann WH: Hyperdinamic circulation in cirrhosis: A historical perspective. Hepatology 20:1356–1358, 1994
MacDougall BRD, Westaby D, Blendis LA: Portal hypertension—25 years of progress. Gut Suppl:S18–S24, 1991
Bina JC, Prata A: A evolu{ie760-2} natural da esquistossomose mansoni em um área endèmica. In Aspectos peculiares da infec{ie760-3} por Schistosoma mansoni. ES Azevedo, G Rebouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didático da UFBA, 1984, pp 13–33
Andrade ZA, Andrade SG: Patologia da esquistossomose hepatoesplènica. In Aspectos peculiares da infec{ie760-4} por Schistosoma mansoni. ES Azevedo, G Rebouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didático da UFBA, 1984, pp 103–131
Rivero MA, Marcial MA, Reyes A: Pathology of pulmonary hypertension on Schistosomiasis mansoni. PR Health Sci J 12:43–45, 1993
Lopes de Faria J, Barbas JV, Fujioka T, Lion MF, Silva UA, Decourt LV: Pulmonary schistosomatic arteriovenous fistulas producing a new cyanotic syndrome in Manson's schistosomiasis. Am Heart J 58:556–567, 1959
Hadengue A, Lebrec D, Benhamou J-P: Pulmonary arterial hypertension in patients with portal hypertension. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Springer-Verlag, 1991, pp 401–411
Rakela J, Krowka MJ: Cardiovascular and pulmonary complications of liver diseases. In Hepatology. A Textbook of Liver Disease, Vol. 1, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1990, pp 530–537
Weiner N: Drugs that inhibit adrenergic nerves and block adrenergic receptors. In The Goodman and Gilman's Pharmacological Basis of Therapeutics, 7th ed. AG Gilman, LS Goodman, TW Rall, F Murad (eds). New York, Macmillan, 1985, pp 181–214
Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J: Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol 1:125–139, 1985
Calès P, Braillon A, Jirón MI, Lebrec D: Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1:37–46, 1984
Kashiwagi T, Kamada T, Abe H: Dynamic studies on the portal hemodynamics by scintiphotosplenoportography. Streamline flow in the human portal vein. Gastroenterology 69:1292–1296, 1975
Fausto N: Hepatic regeneration. In Hepatology. A Textbook of Liver Disease, Vol 1, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1990, pp 49–65
Zoller WG, Wagner DR, Zentner J: Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: Assessment by duplex sonography. Z Gastroenterol 31:425–428, 1993
Feu F, Bordas JM, Luca A, Garcia-Pagan JC, Escorsell A, Bosch J, Rodés J: Reduction of variceal pressure by propranolol: Comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology 18:1082–1089, 1993
Raia S, da Silva LC, Gayotto LCC, Forster SC, Fukushima J, Strauss E: Portal hypertension in schistosomiasis. A long-term follow-up of a randomized trial comparing three types of surgery. Hepatology 20:398–403, 1994
Rights and permissions
About this article
Cite this article
Mies, S., Neto, O.B., Beer, A. et al. Systemic and Hepatic Hemodynamics in Hepatosplenic Manson's Schistosomiasis with and Without Propranolol. Dig Dis Sci 42, 751–761 (1997). https://doi.org/10.1023/A:1018803911915
Issue Date:
DOI: https://doi.org/10.1023/A:1018803911915